| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/14/2007 | EP1761272A1 Compositions containing d-carnosine |
| 03/14/2007 | EP1761253A2 Hyaluronic acid in the enhancement of lens regeneration |
| 03/14/2007 | EP1761248A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 03/14/2007 | EP1504098B1 A method for in vitro molecular evolution of protein function |
| 03/14/2007 | EP1497417B1 Epha2 antigen t epitopes |
| 03/14/2007 | EP1461063B1 Treatment of glioblastoma with thymosin-alpha 1 |
| 03/14/2007 | EP1434878A4 Nucleic acid constructs capable of high efficiency delivery of polynucleotides into dna containing organelles and methods of utilizing same |
| 03/14/2007 | EP1427394B1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/14/2007 | EP1397156B1 Oral administration of parathyroid hormone and calcitonin |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1333799B1 Oral composition providing enhanced tooth stain removal |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1227838B1 Melanoma vaccine and methods of making and using same |
| 03/14/2007 | EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature |
| 03/14/2007 | EP1212068A4 Method of enhancing the efficacy of anti-tumor agents |
| 03/14/2007 | EP1189623B1 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/14/2007 | EP1112057B1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0998941B9 Use of midkine or of anti-midkine antibodies |
| 03/14/2007 | EP0975351B1 Treatment of multiple sclerosis through ingestion of copolymer-1 |
| 03/14/2007 | EP0966302B1 Methods of therapeutic administration of anti-cd40l compounds |
| 03/14/2007 | EP0944648B1 Glp-1 derivatives |
| 03/14/2007 | CN1930305A Methods of using peroxisome proliferator-activated receptor alpha target genes |
| 03/14/2007 | CN1930186A Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 03/14/2007 | CN1930182A Antithrombotic compound |
| 03/14/2007 | CN1929883A Apparatus and methods for enzymatic debridement of skin lesions |
| 03/14/2007 | CN1929867A Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines |
| 03/14/2007 | CN1929861A CTGF as target for the therapy of diabetic nephropathy |
| 03/14/2007 | CN1929858A Use of factor VIIa equivalents for treating trauma |
| 03/14/2007 | CN1929857A N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 03/14/2007 | CN1929856A An agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor |
| 03/14/2007 | CN1929855A Method of inducing or modulating immune response |
| 03/14/2007 | CN1929854A A diffenrentiation- or regeneration-inducing agent for alveoli |
| 03/14/2007 | CN1929853A Neuroprotective dietary supplement |
| 03/14/2007 | CN1929852A An efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (alpha-PGG) and its analogues |
| 03/14/2007 | CN1929828A Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic deseases |
| 03/14/2007 | CN1929734A A follistatin domain containing protein |
| 03/14/2007 | CN1928088A Series connection expression method from virus macrophage inflammatory protein IIN end 15 peptide |
| 03/14/2007 | CN1927888A Recombination albumen of GLP-1 and analogue thereof and human lysozyme fusion and application thereof |
| 03/14/2007 | CN1927883A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
| 03/14/2007 | CN1927880A Odorranagrahami antimicrobialpeptides and application thereof |
| 03/14/2007 | CN1927879A Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 03/14/2007 | CN1927393A Composite collagen gel |
| 03/14/2007 | CN1927392A Composite collagen eye drops |
| 03/14/2007 | CN1927391A Collagen eye drops |
| 03/14/2007 | CN1927390A Compound recipe interferon vaginal spray for preventing and treating human viral infection |
| 03/14/2007 | CN1927389A Application of human interferon containing pharmaceutical composition in preparation of medicine for preventing and treating virus infection of respiratory tract |
| 03/14/2007 | CN1927388A Medicinal composition containing human interferon |
| 03/14/2007 | CN1927387A Application of interleukins-15 in preparation of medicine for tumor immunization therapy and immunotherapy drug |
| 03/14/2007 | CN1927386A Application of NYGGF5 protein and encoding gene thereof in preparation of medicine for inhibiting adipocyte differentiation |
| 03/14/2007 | CN1927385A NK 3 receptor in vivo assay |
| 03/14/2007 | CN1927384A Lung lobe cleaning fluid |
| 03/14/2007 | CN1927232A Process for preparing ganoderma lucidum spore powder and capsule thereof |
| 03/14/2007 | CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 03/14/2007 | CN1304581C Compositions and methods for treating neurodegenerative diseases |
| 03/14/2007 | CN1304578C Ecdysone receptor-based inducible gene expression system |
| 03/14/2007 | CN1304574C Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
| 03/14/2007 | CN1304573C NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour |
| 03/14/2007 | CN1304572C Modified antisense nucleotides complementary to section of human Ha-Ras gene |
| 03/14/2007 | CN1304568C Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 03/14/2007 | CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC |
| 03/14/2007 | CN1304559C Oncolytic microorganism expressing heat shock protein and its application |
| 03/14/2007 | CN1304424C Compounds with growth hormone releasing properties |
| 03/14/2007 | CN1304423C Urotensin-II agonists and antagonists |
| 03/14/2007 | CN1304422C Non-amidated omega-conotoxin VIIA and its prepn process and application |
| 03/14/2007 | CN1304421C Peptides having affinity for the GP 120 viral protein and use thereof |
| 03/14/2007 | CN1304418C Nuclear factor-K B P65 subunit antagonistic peptide and its use |
| 03/14/2007 | CN1304416C Heterocyclic tripeptides as hepatitis C inhibitors |
| 03/14/2007 | CN1304415C Pyrane derivatives as both ACE- and NEP- inhibitors |
| 03/14/2007 | CN1304410C Tumor necrosis factor-Gamma |
| 03/14/2007 | CN1304363C N-methyl-homocysteines and their use as well as process for their production |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304050C Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
| 03/14/2007 | CN1304049C Pharmaceutical composition comprising factor VIIa and factor XIII |
| 03/14/2007 | CN1304048C Pharmaceutical compositions for oral delivery of pharmacologically active agents |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1304046C Liver cancer relative gene DLK1 and its use |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1303977C Pro-micelle pharmaceutical compositions |
| 03/13/2007 | US7190782 Personal communication center performance display and status alert system |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189835 Which allows use of Pichia as host cells for producing large amounts of recombinant proteins |
| 03/13/2007 | US7189833 Prostate cancer gene |
| 03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| 03/13/2007 | US7189829 Thrombin-activatable fibrinolysis inhibitors (TAFI) enzyme molecules; inhibit the breakdown of blood clots, for use in treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease |
| 03/13/2007 | US7189828 use of glycopeptides containing sulfated tyrosines and sialyated, fucosylated N-acetyllactosamino glycans; for treating inflammation, ischemia-reperfusion injury, rheumatoid arthritis, atherosclerosis, leukocyte-mediated lung injury, restenosis, and thrombosis |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189826 Hybridomas cell lines; viricides |
| 03/13/2007 | US7189824 Monoclonal antibody which recognizes an antigen on the surface of tumor vessel endothelial cells; conjugates with diagnostic, chemotherapeutic agents for diagnosis or treatment of tumors |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/13/2007 | US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy |
| 03/13/2007 | US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2007 | US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents |
| 03/13/2007 | US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents |
| 03/13/2007 | US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 03/13/2007 | US7189804 PRO1335 polypeptides |